Dallob, Aimee <br/><br/>
Characterization of etoricoxib, a novel, selective COX-2 inhibitor.  [electronic resource] 

 -  Journal of clinical pharmacology  Jun 2003 
 - 573-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Area Under Curve<br/>Cyclooxygenase 2<br/>Dinoprostone--antagonists & inhibitors<br/>Double-Blind Method<br/>Drug Tolerance<br/>Etoricoxib<br/>Female<br/>Gastric Mucosa--drug effects<br/>Humans<br/>Isoenzymes--antagonists & inhibitors<br/>Lipopolysaccharides--antagonists & inhibitors<br/>Male<br/>Membrane Proteins<br/>Middle Aged<br/>Naproxen--pharmacology<br/>Platelet Aggregation--drug effects<br/>Prostaglandin-Endoperoxide Synthases<br/>Pyridines--blood<br/>Sulfones--blood